P Kontro, S S Oja
Index: Neuroscience 19(3) , 1007-10, (1986)
Full Text: HTML
The effects of taurine and its structural analogues and two new anticonvulsant derivatives, taltrimide and MY-103, on the function of brain dopaminergic systems were studied by assessing their interference with the binding of [3H]spiperone to synaptic membranes isolated from rat striata. Two populations of binding sites were detected. The binding was effectively displaced by (+)butaclamol and dopamine, serotonin being less potent by one order of magnitude. Taurine, taltrimide and MY-103 inhibited spiperone binding moderately. The binding constants of both high- and low-affinity components and the maximal binding capacity of the low-affinity component decreased in the presence of taurine. The results show that taurine and its novel anticonvulsant derivates could modulate the function of striatal dopaminergic systems.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Suloctidil
CAS:54767-75-8 |
C20H35NOS |
|
A repurposing approach identifies off-patent drugs with fung...
2013-02-01 [Eukaryotic Cell 12(2) , 278-87, (2013)] |
|
Inhibition of platelet thromboxane generation by suloctidil ...
1986-01-01 [Haemostasis 16(5) , 362-8, (1986)] |
|
Effects of the antithrombotic drug suloctidil on low density...
1988-01-01 [J. Clin. Chem. Clin. Biochem. 26(1) , 3-6, (1988)] |
|
Suloctidil-induced hepatotoxicity.
[Gastroenterology 95(2) , 490-1, (1988)] |
|
Suloctidil hepatitis: a case presentation.
1987-10-01 [Ir. J. Med. Sci. 156(10) , 290-1, (1987)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
